FIFTH LANE CAPITAL, LP
Follow13F filer, CIK 1858558, Austin, TX
FIFTH LANE CAPITAL, LP reported $1,630,758 across 5 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-06.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-26-009699
- Period
- 2026-06-30
- Reported value
- $1.63M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 55
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PESInew | +18,000 | $257K |
| ASPCnew | +20,368 | $220K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RTACexited | -1,089,815 | -$11.2M |
| OSexited | -322,630 | -$7.74M |
| CEPVexited | -753,500 | -$7.65M |
| HOLXexited | -94,528 | -$7.15M |
| CEPTexited | -526,494 | -$5.73M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001214659-26-009699, largest first. % of portfolio is the value over $1,630,758, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CFNDC1 FD INC | 294,688 | $893K | 54.75% | -35,072 | Timeline | ||
| PESIPERMA-FIX ENVIRONMENTAL SVCS | 18,000 | $257K | 15.77% | new | Timeline | ||
| SBNYLSIGNATURE BK NY DEPOSITARY SHS | 95,551 | $220K | 13.48% | -1,785 | Timeline | ||
| ASPCA SPAC III ACQUISITION CORP | 20,368 | $220K | 13.46% | new | Timeline | ||
| BRDTLA 7.625 31 DEC 2049 A …BRDTLA 7.625 31 DEC 2049 A - PFD | 786,652 | $41.3K | 2.53% | 0 |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RTACRENATUS TACTICAL ACQUIS | 1,089,815 | $11.2M | shares |
| OSONESTREAM INC | 322,630 | $7.74M | shares |
| CEPVCANTOR EQUITY PARTNERS V INC | 753,500 | $7.65M | shares |
| HOLXHOLOGIC INC | 94,528 | $7.15M | shares |
| CEPTCANTOR EQUITY PARTNERS II IN | 526,494 | $5.73M | shares |
| NWAXUNEW AMER ACQUISITION I CORP | 430,000 | $4.46M | shares |
| EAELECTRONIC ARTS INC | 17,500 | $3.57M | shares |
| ACLXARCELLX INC | 31,044 | $3.56M | shares |
| FCRSFUTURECREST ACQUISITION CORP | 278,704 | $2.8M | shares |
| MAGSLISTED FDS TR | 40,000 | $2.32M | shares |
| NWAXNEW AMER ACQUISITION I CORP | 200,000 | $2M | shares |
| FCRSUFUTURECREST ACQUISITION CORP | 190,200 | $1.94M | shares |
| UNHUNITEDHEALTH GROUP INC | 7,000 | $1.89M | shares |
| ABVXABIVAX SA | 15,858 | $1.77M | shares |
| CORZCORE SCIENTIFIC INC NEW | 99,752 | $1.49M | shares |
| NVDANVIDIA CORPORATION | 7,500 | $1.31M | shares |
| VISNVISTANCE NETWORKS INC | 64,552 | $1.17M | shares |
| NKTRNEKTAR THERAPEUTICS | 12,000 | $863K | shares |
| AMDADVANCED MICRO DEVICES INC | 4,000 | $814K | shares |
| ORCLORACLE CORP | 5,000 | $736K | shares |
| TSMTAIWAN SEMICONDUCTOR MANUFAC | 2,000 | $676K | shares |
| TDAYUSA TODAY CO INC | 81,123 | $572K | shares |
| AIVAPARTMENT INVT & MGMT CO | 140,000 | $570K | shares |
| TSLATESLA INC | 1,500 | $558K | shares |
| CVGWCALAVO GROWERS INC | 20,700 | $534K | shares |
| ARMARM HOLDINGS PLC | 3,500 | $529K | shares |
| RNAATRIUM THERAPEUTICS INC | 35,999 | $481K | shares |
| AALAMERICAN AIRLINES GROUP INC | 40,000 | $430K | shares |
| TERNTERNS PHARMACEUTICALS INC | 8,000 | $422K | shares |
| IGVISHARES TR | 5,000 | $400K | shares |
| SIMOSILICON MOTION TECHNOLOGY CO | 3,500 | $393K | shares |
| SMHVANECK ETF TRUST | 1,000 | $383K | shares |
| PLTRPALANTIR TECHNOLOGIES INC | 2,500 | $366K | shares |
| CRWVCOREWEAVE INC | 4,500 | $349K | shares |
| GLDSPDR GOLD TR | 800 | $344K | shares |
| ASTSAST SPACEMOBILE INC | 4,000 | $331K | shares |
| INTCINTEL CORP | 7,500 | $331K | shares |
| RLMDRELMADA THERAPEUTICS INC | 45,000 | $313K | shares |
| APLSAPELLIS PHARMACEUTICALS INC | 7,500 | $302K | shares |
| PPLPPL CORP | 5,817 | $298K | shares |
| BEBLOOM ENERGY CORP | 2,000 | $271K | shares |
| AVRANTERIS TECHNOLOGIES GLOBAL | 47,500 | $264K | shares |
| CRNXCRINETICS PHARMACEUTICALS IN | 7,161 | $260K | shares |
| RKLBROCKET LAB CORP | 3,500 | $225K | shares |
| SABSSAB BIOTHERAPEUTICS INC | 46,500 | $178K | shares |
| RPIDRAPID MICRO BIOSYSTEMS INC | 71,000 | $161K | shares |
| RKTROCKET COS INC | 10,000 | $142K | shares |
| CNTBCONNECT BIOPHARMA HLDGS LTD | 45,000 | $118K | shares |
| NOKNOKIA CORP | 10,000 | $80.4K | shares |
| GTGOODYEAR TIRE & RUBR CO | 10,000 | $66.3K | shares |
| COURCOURSERA INC | 10,000 | $58.2K | shares |
| BURBURFORD CAPITAL LIMITED | 10,000 | $45.2K | shares |
| IKTINHIBIKASE THERAPEUTICS INC | 24,896 | $41.8K | shares |
| CVUCPI AEROSTRUCTURES INC | 10,562 | $41.4K | shares |
| FLDDWFOLD HLDGS INC | 26,193 | $2.88K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001214659-26-009699 | base | 2026-08-06 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-009699 | Quarter ended 2026-06-30 | 2026-08-06 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-26-006310 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-26-001718 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-016241 | Quarter ended 2025-09-30 | 2025-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-011936 | Quarter ended 2025-06-30 | 2025-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-007501 | Quarter ended 2025-03-31 | 2025-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-002894 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-018675 | Quarter ended 2024-09-30 | 2024-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-014590 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-008136 | Quarter ended 2024-03-31 | 2024-05-02 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-002849 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-23-015098 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-23-010700 | Quarter ended 2023-06-30 | 2023-08-03 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-23-007170 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-23-002396 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-22-013587 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-22-010085 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-22-006902 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001858558-22-000002 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set |